DK3236782T3 - Fremgangsmåde til forøgelse af stabiliteten af en sammensætning, der omfatter flerumættede omega-3-fedtsyrer - Google Patents

Fremgangsmåde til forøgelse af stabiliteten af en sammensætning, der omfatter flerumættede omega-3-fedtsyrer Download PDF

Info

Publication number: DK3236782T3
Authority: DK; Denmark
Prior art keywords: procedure; composition containing; containing multi; increasing stability; fat acids
Prior art date: 2014-12-23

Application number

DK15810737.5T

Other languages

English (en)

Inventor

Günter Knaup

Milan Latinovic

Michael Schwarm

Original Assignee

Evonik Operations Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-12-23

Filing date

2015-12-17

Publication date

2020-04-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52344991&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3236782(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-12-17 Application filed by Evonik Operations Gmbh filed Critical Evonik Operations Gmbh

2020-04-27 Application granted granted Critical

2020-04-27 Publication of DK3236782T3 publication Critical patent/DK3236782T3/da

Links

239000002253 acid Substances 0.000 title 1
150000007513 acids Chemical class 0.000 title 1
229920006395 saturated elastomer Polymers 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings or cooking oils characterised by the production or working-up
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/30—Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1882—Polyunsaturated fatty acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Nutrition Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Mycology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Wood Science & Technology (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Botany (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

DK15810737.5T 2014-12-23 2015-12-17 Fremgangsmåde til forøgelse af stabiliteten af en sammensætning, der omfatter flerumættede omega-3-fedtsyrer DK3236782T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP14199989		2014-12-23
PCT/EP2015/080311 WO2016102323A1 (en)	2014-12-23	2015-12-17	Process for increasing the stability of a composition comprising polyunsaturated omega-3 fatty acids

Publications (1)

Publication Number	Publication Date
DK3236782T3 true DK3236782T3 (da)	2020-04-27

Family

ID=52344991

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK15810737.5T DK3236782T3 (da)	2014-12-23	2015-12-17	Fremgangsmåde til forøgelse af stabiliteten af en sammensætning, der omfatter flerumættede omega-3-fedtsyrer

Country Status (24)

Country	Link
US (2)	US10798962B2 (da)
EP (1)	EP3236782B1 (da)
JP (1)	JP6861156B2 (da)
KR (1)	KR102584130B1 (da)
CN (1)	CN107105746B (da)
AU (1)	AU2015371376B2 (da)
BR (1)	BR112017013319B1 (da)
CL (2)	CL2017001614A1 (da)
CO (1)	CO2017005847A2 (da)
DK (1)	DK3236782T3 (da)
ES (1)	ES2781863T3 (da)
HU (1)	HUE048494T2 (da)
IL (1)	IL252481B (da)
MX (1)	MX384154B (da)
MY (1)	MY179033A (da)
PE (1)	PE20171083A1 (da)
PH (1)	PH12017501145A1 (da)
PL (1)	PL3236782T3 (da)
RU (1)	RU2706202C2 (da)
SA (1)	SA517381763B1 (da)
SG (1)	SG11201704396XA (da)
TW (1)	TWI695682B (da)
WO (1)	WO2016102323A1 (da)
ZA (1)	ZA201704820B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN110087493A (zh) *	2016-12-13	2019-08-02	帝斯曼知识产权资产管理有限公司	Pufa盐制剂(ii)
AU2017376402B2 (en) *	2016-12-13	2021-10-28	Dsm Ip Assets B.V.	PUFA salt formulations (I)
KR102628351B1 (ko) *	2017-08-15	2024-01-25	에보니크 오퍼레이션즈 게엠베하	오메가-3 지방산 아미노산 염의 높은 활성 성분 함량을 갖는 정제
EP3586640A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
EP3586642A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Ala enriched polyunsaturated fatty acid compositions
EP3586643A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
EP3586641A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions
US20210392935A1 (en)	2018-11-30	2021-12-23	Evonik Operations Gmbh	Preparation comprising a probiotic strain of the genus bacillus megaterium and a polyunsaturated fatty acid component
BR112021010240A2 (pt)	2018-11-30	2021-08-17	Evonik Operations Gmbh	preparação que compreende uma dispersão de fosfolipídeos e sais de ácidos graxos
WO2020109480A1 (en)	2018-11-30	2020-06-04	Evonik Operations Gmbh	Preparation for use to increase the formation of one or more specialized pro-resolving lipid mediators (spm)
EP3965755A1 (en)	2019-05-06	2022-03-16	Evonik Operations GmbH	Preparation for use in weight management comprising omega-3 fatty acid salts and basic amino acids
US12342842B2 (en)	2019-05-23	2025-07-01	Evonik Operations Gmbh	Preparation for use in enhancing formation of short-chain fatty acids (SCFAs)
CN118252869A (zh) *	2019-08-01	2024-06-28	赢创运营有限公司	包含ω-3脂肪酸盐和来自乳香属物种的胶树脂提取物的制剂
ES3038192T3 (en)	2019-08-08	2025-10-10	Evonik Operations Gmbh	Method of preparing a solid dosage form and a lubricant
EP3804699A1 (en)	2019-10-10	2021-04-14	Evonik Operations GmbH	Method of preparing a solid dosage form and a binder
US20220287345A1 (en)	2019-08-08	2022-09-15	Evonik Operations Gmbh	Solubility enhancement of poorly soluble actives
KR102977459B1 (ko) *	2019-08-08	2026-06-16	에보니크 오퍼레이션즈 게엠베하	다중불포화 지방산 염의 제조를 위한 다운스트림 공정
ES3038193T3 (en)	2019-08-08	2025-10-10	Evonik Operations Gmbh	Method of preparing a solid dosage form and a binder
EP4097201A4 (en) *	2020-01-30	2024-01-24	Silicycle Inc.	METHOD FOR PREPARING A SOLID FORM OF BASIC AMINO ACID SALTS OF POLYUNSATURATED FATTY ACIDS
AU2021213078A1 (en) *	2020-01-30	2022-09-08	Silicycle Inc.	Process for manufacturing solid neutral amino acid salts of polyunsaturated fatty acids
WO2021197971A1 (en)	2020-04-01	2021-10-07	Evonik Operations Gmbh	Preparation for use as antioxidant
EP4125437A1 (en)	2020-04-01	2023-02-08	Evonik Operations GmbH	Preparation for use as vasorelaxant

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2945049A (en)	1959-05-25	1960-07-12	Gen Mills Inc	Salts of basic amino acids and linoleic acid
HU199775B (en) *	1988-03-09	1990-03-28	Nagy Peter Literati	Process for production of formed by fatty acids salts of amin acids and medical compositions containing them
IT1264987B1 (it)	1993-12-14	1996-10-17	Prospa Bv	Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
KR960013387A (ko) *	1994-10-13	1996-05-22	오동빈	Dha과립분말 및 그의 제조방법
CN1463745A (zh) *	2002-06-14	2003-12-31	丁强	一种全元营养素补充剂
US20140199313A1 (en) *	2005-03-02	2014-07-17	Metanomics Gmbh	Process for the Production of Fine Chemicals
US7867538B2 (en) *	2005-12-20	2011-01-11	Archer Daniels Midland Company	Processes of improving the quality of oil and products produced therefrom
KR20090046773A (ko) *	2006-06-05	2009-05-11	오션 뉴트리션 캐나다 리미티드	개선된 쉘을 가지는 마이크로캡슐
EP2037746A4 (en) *	2006-06-29	2010-09-22	Martek Biosciences Corp	GREATEST OIL COMPOSITIONS AND MANUFACTURING METHOD THEREFOR
US8975299B2 (en) *	2007-11-01	2015-03-10	Enzymotec Ltd.	Lipid mixture for infant nutrition
EP2366766B8 (en)	2010-03-09	2017-04-19	Stepan Specialty Products, LLC	Method of treating an edible oil and oil thus obtained
US8609138B2 (en) *	2010-06-30	2013-12-17	Mochida Pharmaceutical Co., Ltd.	ω3 fatty acid compound preparation
WO2014011895A2 (en) *	2012-07-11	2014-01-16	Thetis Pharmaceuticals Llc	High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof

2015
- 2015-12-17 KR KR1020177016894A patent/KR102584130B1/ko active Active
- 2015-12-17 CN CN201580070557.5A patent/CN107105746B/zh active Active
- 2015-12-17 JP JP2017533769A patent/JP6861156B2/ja active Active
- 2015-12-17 ES ES15810737T patent/ES2781863T3/es active Active
- 2015-12-17 DK DK15810737.5T patent/DK3236782T3/da active
- 2015-12-17 US US15/538,825 patent/US10798962B2/en active Active
- 2015-12-17 HU HUE15810737A patent/HUE048494T2/hu unknown
- 2015-12-17 WO PCT/EP2015/080311 patent/WO2016102323A1/en not_active Ceased
- 2015-12-17 RU RU2017125962A patent/RU2706202C2/ru active
- 2015-12-17 PL PL15810737T patent/PL3236782T3/pl unknown
- 2015-12-17 AU AU2015371376A patent/AU2015371376B2/en active Active
- 2015-12-17 MY MYPI2017702241A patent/MY179033A/en unknown
- 2015-12-17 EP EP15810737.5A patent/EP3236782B1/en active Active
- 2015-12-17 PE PE2017001087A patent/PE20171083A1/es unknown
- 2015-12-17 BR BR112017013319-9A patent/BR112017013319B1/pt active IP Right Grant
- 2015-12-17 MX MX2017007846A patent/MX384154B/es unknown
- 2015-12-17 SG SG11201704396XA patent/SG11201704396XA/en unknown
- 2015-12-18 TW TW104142798A patent/TWI695682B/zh not_active IP Right Cessation
2017
- 2017-05-24 IL IL252481A patent/IL252481B/en unknown
- 2017-06-14 CO CONC2017/0005847A patent/CO2017005847A2/es unknown
- 2017-06-18 SA SA517381763A patent/SA517381763B1/ar unknown
- 2017-06-19 PH PH12017501145A patent/PH12017501145A1/en unknown
- 2017-06-19 CL CL2017001614A patent/CL2017001614A1/es unknown
- 2017-07-17 ZA ZA2017/04820A patent/ZA201704820B/en unknown
2020
- 2020-01-17 CL CL2020000141A patent/CL2020000141A1/es unknown
- 2020-08-18 US US16/947,809 patent/US11805798B2/en active Active

Also Published As

Publication number	Publication date
SA517381763B1 (ar)	2021-06-06
CL2017001614A1 (es)	2018-01-12
CO2017005847A2 (es)	2017-08-31
TWI695682B (zh)	2020-06-11
EP3236782B1 (en)	2020-02-05
HUE048494T2 (hu)	2020-07-28
US11805798B2 (en)	2023-11-07
MX2017007846A (es)	2017-09-19
ES2781863T3 (es)	2020-09-08
IL252481A0 (en)	2017-07-31
RU2017125962A3 (da)	2019-06-18
WO2016102323A1 (en)	2016-06-30
PH12017501145A1 (en)	2018-03-05
CA2969159A1 (en)	2016-06-30
PE20171083A1 (es)	2017-08-03
EP3236782A1 (en)	2017-11-01
TW201639464A (zh)	2016-11-16
US10798962B2 (en)	2020-10-13
US20170360072A1 (en)	2017-12-21
KR20170094788A (ko)	2017-08-21
RU2017125962A (ru)	2019-01-24
SG11201704396XA (en)	2017-07-28
AU2015371376B2 (en)	2020-04-23
RU2706202C2 (ru)	2019-11-15
KR102584130B1 (ko)	2023-10-04
JP6861156B2 (ja)	2021-04-21
PL3236782T3 (pl)	2020-06-29
BR112017013319A2 (pt)	2018-04-10
US20200375235A1 (en)	2020-12-03
MX384154B (es)	2025-03-14
MY179033A (en)	2020-10-26
CL2020000141A1 (es)	2020-06-05
BR112017013319B1 (pt)	2021-11-30
IL252481B (en)	2021-08-31
ZA201704820B (en)	2019-06-26
NZ732378A (en)	2024-07-05
CN107105746B (zh)	2020-11-10
JP2018502085A (ja)	2018-01-25
AU2015371376A1 (en)	2017-06-22
CN107105746A (zh)	2017-08-29

Publication	Publication Date	Title
DK3096741T3 (da)	2020-09-28	Fremgangsmåde til fremstillingen af hybridosomer
DK3317400T3 (da)	2021-01-18	Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3192902T3 (da)	2019-07-15	Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3372585T3 (da)	2022-05-30	Fremgangsmåde til fremstillingen af en diarylthiohydantoinforbindelse
DK3126499T3 (da)	2020-07-20	Sammensætninger til modulering af sod-1-ekspression
DK3174858T3 (da)	2019-07-15	Fremgangsmåde til fremstilling af pyrazoler
DK3236783T3 (da)	2020-04-27	Fremgangsmåde til forøgelse af stabiliteten af en sammensætning, der omfatter flerumættede omega-6-fedtsyrer
DK3220909T3 (da)	2020-11-23	Bupropion til modulation af lægemiddelplasmaniveauer af dextrometorphan
DK3325443T3 (da)	2022-07-18	Fremgangsmåde til fremstilling af pridopidin
DK3294700T3 (da)	2020-04-14	Fremgangsmåde til fremstilling af limonen-4-ol
DK3233813T3 (da)	2022-03-07	Fremgangsmåder til fremstilling af oxathiazin-lignende forbindelser
DK3166611T3 (da)	2020-12-07	Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxypicolinsyrer
DK3280408T3 (da)	2020-02-03	Fremgangsmåde til fremstilling af dicycloplatin
DK3177931T3 (da)	2019-07-08	Fremgangsmåde til bestemmelse af stoffers evne til at binde til analytaktive steder
DK3191498T3 (da)	2020-12-21	Fremgangsmåde til fremstilling af 2'-o-fucosyllactose
DK3295941T3 (da)	2020-08-24	Fremgangsmåde til fremstilling af form a af grapiprant
DK3137449T3 (da)	2020-03-02	Fremgangsmåder til fremstilling af substituerede cycloseriner
DK2910535T3 (da)	2019-07-01	Sammensætning til anvendelse af ekspanderet perlit
DK3274143T3 (da)	2019-11-25	Fremgangsmåde til fremstilling af lignocellulosematerialer
DK3454637T3 (da)	2021-08-30	Fremgangsmåde til naturlig prægning af en salat
DK3328574T3 (da)	2019-11-11	Fremgangsmåde til fremstilling af en monotektisk legering
DK3116854T3 (da)	2022-05-02	Ny fremgangsmåde til fremstilling af prostaglandiner med høj renhed
DK3324936T3 (da)	2022-12-12	Fremgangsmåde til fremstilling af en bortezomib-ester-opløsning
DK3172757T3 (da)	2020-03-16	Fremgangsmåde til automatisk korrektion af astigmastisme
DK3102264T3 (da)	2020-06-22	Kanyle til administrering af en væske